WSJ What’s News The Wall Street Journal

A.M. Edition for June 11. Risky trades are roaring in popularity, driven by amateur investors piling into meme stocks and long-shot bets. The WSJ’s Hannah Miao says these self-proclaimed degenerate traders have Wall Street paying attention. Plus, derivatives regulator Christy Goldsmith Romero emerges as the White House’s top pick to head the FDIC. And, one prison in Brazil trades guard dogs for geese—with great success. Luke Vargas hosts.



Sign up for the WSJ's free What's News newsletter.

Learn more about your ad choices. Visit megaphone.fm/adchoices

P.M. Edition for June 10. Economists say higher inflation than the 2% the Federal Reserve is aiming for could help the Fed get out of possible downturns. But, as economics reporter Justin Lahart points out, inflation is unpopular among consumers. And Apple announces a software update that includes generative artificial intelligence. Plus, extreme weather is putting crops like olives, cocoa and grapes at risk. Reporter Jon Emont says that is raising prices for goods like olive oil, chocolate and wine. Alex Ossola hosts.



Sign up for the WSJ's free What's News newsletter.

Learn more about your ad choices. Visit megaphone.fm/adchoices

A.M. Edition for June 10. Nationalist parties make a strong showing in European Union elections, dealing a setback to leaders in France and Germany. The WSJ’s Laurence Norman says the results could influence the EU’s agenda on migration and the environment. Plus, Israeli Prime Minister Benjamin Netanayahu’s top rival quits the government over his handling of the war in Gaza. And activist investor Elliott takes a big stake in Southwest Airlines. Luke Vargas hosts.



Sign up for the WSJ's free What's News newsletter.

Learn more about your ad choices. Visit megaphone.fm/adchoices

GLP-1 drugs like Ozempic, Wegovy, Mounjaro and Zepbound have been revolutionary for weight loss. They’re also sparking big changes in many industries – from food to medicine. Wall Street Journal tech editor Bradley Olson – who himself took a GLP-1 drug – and audio reporter Jessica Mendoza have been documenting impacts of this new class of drugs in a series – “Trillion Dollar Shot” – for our sister podcast The Journal. They answer listener questions on how it’s transforming bodies, fortunes and industries. Luke Vargas hosts.



Further Reading

The Quest for Treatments to Keep Weight Off After Ozempic 

Can Ozempic Maker Novo Nordisk Keep Up Its Momentum? 

How Drugs Like Ozempic Are Changing What We Think About Weight Loss 

Learn more about your ad choices. Visit megaphone.fm/adchoices

Why is Spotify hiking its premium price? And how are J.M. Smucker and Lululemon dealing with lower consumer spending? Plus, what’s behind the wild moves of GameStop’s stock? Host Francesca Fontana discusses the biggest stock moves of the week and the news that drove them.

Learn more about your ad choices. Visit megaphone.fm/adchoices

P.M. Edition for June 7. A 2017 tax overhaul is set to expire at the end of 2025, but tax policy reporter Richard Rubin says what comes after will depend on the outcome of this year’s election. And U.S. job numbers for May were higher than economists predicted, but unemployment also rose, painting a complicated picture of the economy. Plus, Donald Trump’s Mar-a-Lago is a South Florida gem, but just how much it is worth is a matter of dispute, as Wall Street Journal reporter E.B. Solomont discusses with Tali Arbel. Alex Ossola hosts.



Sign up for the WSJ's free What's News newsletter.

Learn more about your ad choices. Visit megaphone.fm/adchoices